Skip to main content
Top
Published in: Archives of Virology 3/2017

01-03-2017 | Original Article

Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors

Authors: María Belén Pisano, Domingo Balderramo, Maribel Martínez Wassaf, Martín Lotto, Yanina Carlino, Viviana Elizabeth Ré, José D. Debes

Published in: Archives of Virology | Issue 3/2017

Login to get access

Abstract

Infection with hepatitis E virus (HEV) leads to acute hepatitis infection in immunocompetent hosts. HEV genotype 3 can present with high frequency and lead to chronic infection in individuals with a compromised immune system. The risk factors related to increased seroprevalence or chronicity in this population are not entirely understood. Moreover, most studies addressing risk factors for HEV in non-endemic areas come from developed areas such as North America and Europe. In this study we evaluated seroprevalence, chronicity and risk factors for HEV in 120 transplant recipients and 88 patients on dialysis in Argentina. We found a significantly higher seroprevalence of HEV IgG in those undergoing dialysis compared with healthy controls (10.2% and 4.3% respectively, p = 0.03). No difference in HEV seroprevalence was observed between healthy controls and transplant recipients (5.8%). We found no association between previously identified risk factors for HEV, such as pork consumption or use of tacrolimus, and HEV seroprevalence. In univariate and multivariate analyses, consumption of fish was associated with higher seroprevalence of HEV (OR = 9.33; 95% CI: 2.07–42.2; p = 0.04). None of the samples showed HEV RNA amplification, indicating that chronicity does not seem to be an issue in these cohorts. Our results show increased seroprevalence of HEV in individuals undergoing dialysis but not in transplant recipients. We also found that fish consumption can be a potential risk factor for acquiring HEV.
Literature
1.
go back to reference Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J et al (2012) Hepatitis E. Lancet 379(9835):2477–2488CrossRefPubMed Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J et al (2012) Hepatitis E. Lancet 379(9835):2477–2488CrossRefPubMed
3.
go back to reference Nijskens CM, Pas SD, Cornelissen J, Caliskan K, Hoek RA, Hesselink RA et al (2016) Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity. J Clin Virol 74:82–87CrossRefPubMed Nijskens CM, Pas SD, Cornelissen J, Caliskan K, Hoek RA, Hesselink RA et al (2016) Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: Clinical relevance and impact on patient morbidity. J Clin Virol 74:82–87CrossRefPubMed
4.
go back to reference Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J et al (2013) Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol 85(2):266–271CrossRefPubMed Harrison A, Scobie L, Crossan C, Parry R, Johnston P, Stratton J et al (2013) Hepatitis E seroprevalence in recipients of renal transplants or haemodialysis in southwest England: a case-control study. J Med Virol 85(2):266–271CrossRefPubMed
5.
go back to reference Mobaien AR, Mohammadi R, Sorouri R, Sadeghi K (2013) Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan Province, Islamic Republic of Iran. East Mediterr Health J 19(7):608–612PubMed Mobaien AR, Mohammadi R, Sorouri R, Sadeghi K (2013) Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan Province, Islamic Republic of Iran. East Mediterr Health J 19(7):608–612PubMed
6.
go back to reference Scotto G, Aucella F, Grandaliano G, Martinelli D, Querques M, Gesuete A et al (2015) Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy. World J Gastroenterol 21(11):3266–3273PubMedPubMedCentral Scotto G, Aucella F, Grandaliano G, Martinelli D, Querques M, Gesuete A et al (2015) Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy. World J Gastroenterol 21(11):3266–3273PubMedPubMedCentral
7.
go back to reference Pas SD, de Man RA, Mulders C, Balk AH, Van Hal PT, Weimar W et al (2012) Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis. 18(5):869–872CrossRefPubMedPubMedCentral Pas SD, de Man RA, Mulders C, Balk AH, Van Hal PT, Weimar W et al (2012) Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis. 18(5):869–872CrossRefPubMedPubMedCentral
8.
go back to reference Behrendt P, Steinmann E, Manns MP, Wedemeyer H (2014) The impact of hepatitis E in the liver transplant setting. J Hepatol 61(6):1418–1429CrossRefPubMed Behrendt P, Steinmann E, Manns MP, Wedemeyer H (2014) The impact of hepatitis E in the liver transplant setting. J Hepatol 61(6):1418–1429CrossRefPubMed
9.
go back to reference Munné MS, Vladimirsky S, Otegui L, Brajterman L, Castro R, Soto S et al (2006) Molecular characterization of hepatitis E virus in three acute liver failure cases in children in Argentina. Acta Gastroenterol Latinoam 36(3):125–130PubMed Munné MS, Vladimirsky S, Otegui L, Brajterman L, Castro R, Soto S et al (2006) Molecular characterization of hepatitis E virus in three acute liver failure cases in children in Argentina. Acta Gastroenterol Latinoam 36(3):125–130PubMed
10.
go back to reference Munné MS, Altabert NR, Vladimirsky SN, Moreiro R, Mares LO, Soto SS et al (2011) Identifications of polyphyletic variants in acute hepatitis suggest an underdiagnosed circulation of hepatitis E virus in Argentina. J Clin Virol 52(2):138–141CrossRefPubMed Munné MS, Altabert NR, Vladimirsky SN, Moreiro R, Mares LO, Soto SS et al (2011) Identifications of polyphyletic variants in acute hepatitis suggest an underdiagnosed circulation of hepatitis E virus in Argentina. J Clin Virol 52(2):138–141CrossRefPubMed
11.
go back to reference Munné MS, Vladimirsky S, Otegui L, Castro R, Brajterman L, Soto S et al (2006) Identification of the first strain of swine hepatitis E virus in South America and prevalence of anti-HEV antibodies in swine in Argentina. J Med Virol 78(12):1579–1583CrossRefPubMed Munné MS, Vladimirsky S, Otegui L, Castro R, Brajterman L, Soto S et al (2006) Identification of the first strain of swine hepatitis E virus in South America and prevalence of anti-HEV antibodies in swine in Argentina. J Med Virol 78(12):1579–1583CrossRefPubMed
12.
go back to reference Martínez Wassaf MG, Pisano MB, Barril PA, Elbarcha OC, Pinto MA, Mendes de Oliveira J et al (2014) First detection of hepatitis E virus in central Argentina: environmental and serological survey. J Clin Virol 61(3):334–339CrossRefPubMed Martínez Wassaf MG, Pisano MB, Barril PA, Elbarcha OC, Pinto MA, Mendes de Oliveira J et al (2014) First detection of hepatitis E virus in central Argentina: environmental and serological survey. J Clin Virol 61(3):334–339CrossRefPubMed
13.
go back to reference Rey J, Findor JA, Daruich JR, Velazco CC, Igartua EB, Schmee E et al (1997) Prevalence of IgG anti-HEV in Buenos Aires, a non endemic area for hepatitis E. J Travel Med 4(2):100–101CrossRefPubMed Rey J, Findor JA, Daruich JR, Velazco CC, Igartua EB, Schmee E et al (1997) Prevalence of IgG anti-HEV in Buenos Aires, a non endemic area for hepatitis E. J Travel Med 4(2):100–101CrossRefPubMed
14.
go back to reference Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M et al (1999) Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 6(1):53–57CrossRefPubMed Fainboim H, González J, Fassio E, Martínez A, Otegui L, Eposto M et al (1999) Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 6(1):53–57CrossRefPubMed
15.
go back to reference Munné MS, Altabert NR, Otegui MLO, Vladimirsky SN, Moreiro R, Espul MP et al (2014) Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina. Ann Hepatol 13(5):496–502PubMed Munné MS, Altabert NR, Otegui MLO, Vladimirsky SN, Moreiro R, Espul MP et al (2014) Updating the knowledge of hepatitis E: new variants and higher prevalence of anti-HEV in Argentina. Ann Hepatol 13(5):496–502PubMed
16.
go back to reference Debes J, Martínez Wassaf M, Pisano MB, Isa MB, Lotto M, Marianelli LG et al (2016) Increased hepatitis E virus seroprevalence correlates with lower CD4+ cell counts in HIV-infected persons in Argentina. PlosOne 11(7):e0160082CrossRef Debes J, Martínez Wassaf M, Pisano MB, Isa MB, Lotto M, Marianelli LG et al (2016) Increased hepatitis E virus seroprevalence correlates with lower CD4+ cell counts in HIV-infected persons in Argentina. PlosOne 11(7):e0160082CrossRef
17.
go back to reference Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK, Pierson FW et al (2002) Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol 40(4):1326–1332CrossRefPubMedPubMedCentral Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK, Pierson FW et al (2002) Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol 40(4):1326–1332CrossRefPubMedPubMedCentral
18.
go back to reference Rostamzadeh Khameneh Z, Sepehrvand N, Masudi S (2011) Seroprevalence of hepatitis E among Iranian renal transplant recipients. Hepat Mon 11(8):646–651CrossRefPubMedPubMedCentral Rostamzadeh Khameneh Z, Sepehrvand N, Masudi S (2011) Seroprevalence of hepatitis E among Iranian renal transplant recipients. Hepat Mon 11(8):646–651CrossRefPubMedPubMedCentral
19.
go back to reference Hoerning A, Hegen B, Wingen AM, Cetiner M, Lainka E, Kathemann S et al (2012) Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients–a single-center experience. Pediatr Transplant 16(7):742–747CrossRefPubMed Hoerning A, Hegen B, Wingen AM, Cetiner M, Lainka E, Kathemann S et al (2012) Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients–a single-center experience. Pediatr Transplant 16(7):742–747CrossRefPubMed
20.
go back to reference Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C et al (2011) Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140(5):1481–1489CrossRefPubMed Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C et al (2011) Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 140(5):1481–1489CrossRefPubMed
21.
go back to reference Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F et al (2011) Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 17:30–37CrossRefPubMedPubMedCentral Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F et al (2011) Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 17:30–37CrossRefPubMedPubMedCentral
22.
go back to reference Gérolami R, Moal V, Colson P (2008) Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 358(8):859–860CrossRefPubMed Gérolami R, Moal V, Colson P (2008) Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 358(8):859–860CrossRefPubMed
23.
go back to reference Gérolami R, Moal V, Picard C, Colson P (2009) Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 50(3):622–624CrossRefPubMed Gérolami R, Moal V, Picard C, Colson P (2009) Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 50(3):622–624CrossRefPubMed
24.
go back to reference Haagsma EB, Niesters HG, Van Den Berg AP, Riezebos-Brilman A, Porte JR, Vennema H et al (2009) Prevalence of Hepatitis E Virus Infection in Liver Transplant Recipients. Liver Transplant 15(10):1225–1228CrossRef Haagsma EB, Niesters HG, Van Den Berg AP, Riezebos-Brilman A, Porte JR, Vennema H et al (2009) Prevalence of Hepatitis E Virus Infection in Liver Transplant Recipients. Liver Transplant 15(10):1225–1228CrossRef
25.
go back to reference Junge N, Pischke S, Baumann U, Goldschmidt I, Manns M, Wedemeyer H et al (2013) Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 17(4):343–347CrossRefPubMed Junge N, Pischke S, Baumann U, Goldschmidt I, Manns M, Wedemeyer H et al (2013) Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 17(4):343–347CrossRefPubMed
26.
go back to reference Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, ten Kate FJ et al (2013) Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 32(1):78–85CrossRefPubMed Koning L, Pas SD, de Man RA, Balk AH, de Knegt RJ, ten Kate FJ et al (2013) Clinical implications of chronic hepatitis E virus infection in heart transplant recipients. J Heart Lung Transplant 32(1):78–85CrossRefPubMed
27.
go back to reference Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B et al (2013) Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 85(3):462–471CrossRefPubMed Moal V, Legris T, Burtey S, Morange S, Purgus R, Dussol B et al (2013) Infection with hepatitis E virus in kidney transplant recipients in southeastern France. J Med Virol 85(3):462–471CrossRefPubMed
28.
go back to reference Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY, Haagsma EB, Jaksch P, Bejvl I et al (2013) Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 32(3):341–346CrossRefPubMed Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY, Haagsma EB, Jaksch P, Bejvl I et al (2013) Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 32(3):341–346CrossRefPubMed
29.
go back to reference Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R (2013) Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 20(4):e138–e140CrossRefPubMed Naik A, Gupta N, Goel D, Ippagunta SK, Sharma RK, Aggarwal R (2013) Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area. J Viral Hepat 20(4):e138–e140CrossRefPubMed
30.
go back to reference Taremi M, Khoshbaten M, Gachkar L, Ehsani Ardakani M, Zali M (2005) Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC Infect Dis 5:36CrossRefPubMedPubMedCentral Taremi M, Khoshbaten M, Gachkar L, Ehsani Ardakani M, Zali M (2005) Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran. BMC Infect Dis 5:36CrossRefPubMedPubMedCentral
31.
go back to reference Beladi Mousavi SS, Motemednia F, Beladi Mousavi M (2014) Epidemiology of hepatitis e virus infection in patients on chronic hemodialysis. Jundishapur J Microbiol 7(5):e6993CrossRefPubMedPubMedCentral Beladi Mousavi SS, Motemednia F, Beladi Mousavi M (2014) Epidemiology of hepatitis e virus infection in patients on chronic hemodialysis. Jundishapur J Microbiol 7(5):e6993CrossRefPubMedPubMedCentral
32.
go back to reference Uçar E, Cetin M, Kuvandik C, Helvaci MR, Güllü M, Hüzmeli C (2009) Hepatitis E virus seropositivity in hemodialysis patients in Hatay province, Turkey. Mikrobiyol Bul 43(2):299–302PubMed Uçar E, Cetin M, Kuvandik C, Helvaci MR, Güllü M, Hüzmeli C (2009) Hepatitis E virus seropositivity in hemodialysis patients in Hatay province, Turkey. Mikrobiyol Bul 43(2):299–302PubMed
33.
go back to reference Lee YH, Ha Y, Ahn KK, Chae C (2009) Localisation of swine hepatitis E virus in experimentally infected pigs. Vet J 179:417–421CrossRefPubMed Lee YH, Ha Y, Ahn KK, Chae C (2009) Localisation of swine hepatitis E virus in experimentally infected pigs. Vet J 179:417–421CrossRefPubMed
34.
35.
go back to reference Emerson S, Arankalle V, Purcell R (2005) Thermal stability of hepatitis E virus. J Infect Dis 192:930–933CrossRefPubMed Emerson S, Arankalle V, Purcell R (2005) Thermal stability of hepatitis E virus. J Infect Dis 192:930–933CrossRefPubMed
36.
go back to reference Cui W, Sun Y, Xu A, Gao R, Gong L, Zhang L et al (2016) Hepatitis E seroprevalence and related risk factors among seafood processing workers: a cross-sectional survey in Shandong Province, China. Int J Infect Dis 49:62–66CrossRefPubMed Cui W, Sun Y, Xu A, Gao R, Gong L, Zhang L et al (2016) Hepatitis E seroprevalence and related risk factors among seafood processing workers: a cross-sectional survey in Shandong Province, China. Int J Infect Dis 49:62–66CrossRefPubMed
Metadata
Title
Hepatitis E virus infection in patients on dialysis and in solid organ transplant recipients in Argentina: exploring associated risk factors
Authors
María Belén Pisano
Domingo Balderramo
Maribel Martínez Wassaf
Martín Lotto
Yanina Carlino
Viviana Elizabeth Ré
José D. Debes
Publication date
01-03-2017
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2017
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-3171-6

Other articles of this Issue 3/2017

Archives of Virology 3/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.